2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$4.39-$0.06 (-1.24%)
Price as of Jul 14, 2026 4:10 PM EDT- $288.2MMarket Cap
- 442.12%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$4.39-$0.06 (-1.24%)
PRLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.44 | ||
Change | -$0.36 (-7.60%) | ||
Open | $4.73 | ||
High | $4.73 | ||
Low | $4.41 | ||
Previous Close | $4.80 | ||
Volume | 320,592 | ||
30-Day Average Volume | 603,384 | ||
1-Week Change | -11.02% | ||
1-Month Change | -1.11% | ||
1-Year Change | 442.12% | ||
3-Year Change | -4.31% | ||
5-Year Change | -83.51% | ||
Fundamentals | |||
Shares Outstanding | 64.9M | ||
Total Assets | $119.6M | ||
Market Cap | $288.2M | ||
Enterprise Value | $266.5M | ||
Period: QTR TTM FY | |||
Revenue | $4.6M | ||
Net Income | -$10.4M | ||
Free Cash Flow | -$21.7M | ||
EBIT | -$10.4M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $42.9M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 58 | ||
P/B | 5 | ||
P/E | -34 | ||
PEG | -1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue